Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis.

Chang JT, Shebl FM, Pfeiffer RM, Biryahwaho B, Graubard BI, Mbulaiteye SM.

Infect Agent Cancer. 2013 Jan 16;8(1):3. doi: 10.1186/1750-9378-8-3.


Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda.

Biryahwaho B, Dollard SC, Pfeiffer RM, Shebl FM, Munuo S, Amin MM, Hladik W, Parsons R, Mbulaiteye SM.

J Infect Dis. 2010 Nov 1;202(9):1347-53. doi: 10.1086/656525.


Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R, Beral V.

AIDS. 1997 Nov;11(13):1619-26.


Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda.

Wawer MJ, Eng SM, Serwadda D, Sewankambo NK, Kiwanuka N, Li C, Gray RH.

Sex Transm Dis. 2001 Feb;28(2):77-81.


Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans.

Shebl FM, Emmanuel B, Bunts L, Biryahwaho B, Kiruthu C, Huang ML, Pfeiffer RM, Casper C, Mbulaiteye SM.

J Med Virol. 2013 Sep;85(9):1602-10. doi: 10.1002/jmv.23613.


The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.

Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C; Uganda Kaposi's Sarcoma Study Group.

Int J Cancer. 2003 Jan 10;103(2):226-32.


Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population.

Malope BI, Pfeiffer RM, Mbisa G, Stein L, Ratshikhopha EM, O'Connell DL, Sitas F, MacPhail P, Whitby D.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):351-5.


Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.

Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ.

AIDS. 2003 Aug 15;17(12):1847-51.


Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Stolka K, Ndom P, Hemingway-Foday J, Iriondo-Perez J, Miley W, Labo N, Stella J, Abassora M, Woelk G, Ryder R, Whitby D, Smith JS.

Cancer Epidemiol. 2014 Apr;38(2):137-43. doi: 10.1016/j.canep.2014.02.006. Epub 2014 Mar 13.


Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.

Chang Y, Ziegler J, Wabinga H, Katangole-Mbidde E, Boshoff C, Schulz T, Whitby D, Maddalena D, Jaffe HW, Weiss RA, Moore PS.

Arch Intern Med. 1996 Jan 22;156(2):202-4.


Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.

Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C; Uganda Kaposi's Sarcoma Study Group.

Int J Cancer. 2003 Jan 10;103(2):233-40.


Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF.

Int J Cancer. 1998 Aug 12;77(4):543-8.


Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.

Malope-Kgokong BI, Macphail P, Mbisa G, Ratshikhopha E, Maskew M, Stein L, Sitas F, Whitby D.

Infect Agent Cancer. 2010 Aug 31;5:14. doi: 10.1186/1750-9378-5-14.


HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study.

Guech-Ongey M, Verboom M, Pfeiffer RM, Schulz TF, Ndugwa CM, Owor AM, Bakaki PM, Bhatia K, Figueiredo C, Eiz-Vesper B, Blasczyk R, Mbulaiteye SM.

Infect Agent Cancer. 2010 Nov 18;5:21. doi: 10.1186/1750-9378-5-21.


Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.

Kourí V, Eng SM, Rodríguez ME, Resik S, Orraca O, Moore PS, Chang Y.

Rev Panam Salud Publica. 2004 May;15(5):320-5.


Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C.

J Natl Cancer Inst. 2001 Feb 7;93(3):194-202.


Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily.

Anderson LA, Lauria C, Romano N, Brown EE, Whitby D, Graubard BI, Li Y, Messina A, Gafà L, Vitale F, Goedert JJ.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3435-43. doi: 10.1158/1055-9965.EPI-08-0671.


A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.

Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C.

Br J Cancer. 2006 May 22;94(10):1504-9.


Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily.

Goedert JJ, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson LA, Madsen C, Preiss LR, Airola M, Graubard BI, Messina A, Lauria C, Romano N.

Infect Agent Cancer. 2010 Dec 2;5(1):23. doi: 10.1186/1750-9378-5-23.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk